{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:20Z","timestamp":1791907280760,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jns.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T17:08:12Z","timestamp":1436029692000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus"],"prefix":"10.1016","volume":"357","author":[{"given":"Madoka","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Fusegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostadin","family":"Karagiozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2015.07.001_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.jns.2015.07.001_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature12536","article-title":"Microbial production of short-chain alkanes","volume":"502","author":"Choi","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jns.2015.07.001_bb0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.07.001_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2015.07.001_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-510X(65)90016-X","article-title":"The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics","volume":"2","author":"Hakim","year":"1965","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.07.001_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jns.2015.07.001_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-8454-7-18","article-title":"Study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study","volume":"7","author":"Hashimoto","year":"2010","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.jns.2015.07.001_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8454-5-10","article-title":"Multiplicity of cerebrospinal fluid functions: new challenges in health and disease","volume":"5","author":"Johanson","year":"2008","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.jns.2015.07.001_bb0045","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1073\/pnas.0701585104","article-title":"Lipocalin-type prostaglandin D synthase\/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid","volume":"104","author":"Kanekiyo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.07.001_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2015.07.001_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.2012.01676.x","article-title":"European iNPH Multicentre Study Group. One-year outcome in the European multicentre study on iNPH","volume":"126","author":"Klinge","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2015.07.001_bb0060","doi-asserted-by":"crossref","first-page":"e93717","DOI":"10.1371\/journal.pone.0093717","article-title":"Increased gamma-secretase activity in idiopathic normal pressure hydrocephalus patients with beta-amyloid pathology","volume":"9","author":"Laitera","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.07.001_bb0065","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","article-title":"Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42","volume":"60","author":"Maddalena","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2015.07.001_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2045-8118-10-22","article-title":"Influence of comorbidities in idiopathic normal pressure hydrocephalus \u2014 research and clinical care. A report of the ISHCSF task force on comorbidities in INPH","volume":"10","author":"Malm","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jns.2015.07.001_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/3-211-32318-X_48","article-title":"International NPH Consultant Group. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date","volume":"95","author":"Marmarou","year":"2005","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.jns.2015.07.001_bb0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3171\/jns.2005.102.6.0987","article-title":"Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients","volume":"102","author":"Marmarou","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jns.2015.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/clinchem\/42.12.1984","article-title":"Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids","volume":"42","author":"Melegos","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jns.2015.07.001_bb0090","doi-asserted-by":"crossref","first-page":"e74453","DOI":"10.1371\/journal.pone.0074453","article-title":"Leucine-rich alpha2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex","volume":"8","author":"Miyajima","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.07.001_bb0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","article-title":"Soluble amyloid precursor protein alpha in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus","volume":"20","author":"Miyajima","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2015.07.001_bb0100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2176\/nmc.52.775","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus: second edition","volume":"52","author":"Mori","year":"2012","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.jns.2015.07.001_bb0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3171\/jns.2001.95.6.0970","article-title":"Management of idiopathic normal-pressure hydrocephalus: a multi-institutional study conducted in Japan","volume":"95","author":"Mori","year":"2001","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jns.2015.07.001_bb0110","doi-asserted-by":"crossref","first-page":"e0119973","DOI":"10.1371\/journal.pone.0119973","article-title":"Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade","volume":"10","author":"Moriya","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.07.001_bb0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.wneu.2014.08.004","article-title":"Use of external lumbar cerebrospinal fluid drainage and lumboperitoneal shunts with strata NSC valves in idiopathic normal pressure hydrocephalus: a single-center experience","volume":"83","author":"Nakajima","year":"2014","journal-title":"World Neurosurg."},{"key":"10.1016\/j.jns.2015.07.001_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-8118-11-9","article-title":"Association of lipocalin-type prostaglandin D synthase with disproportionately enlarged subarachnoid-space in idiopathic normal pressure hydrocephalus","volume":"11","author":"Nishida","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jns.2015.07.001_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0029(20010101)52:1<31::AID-JEMT5>3.0.CO;2-T","article-title":"Ageing choroid plexus-cerebrospinal fluid system","volume":"52","author":"Preston","year":"2001","journal-title":"Microsc. Res. Tech."},{"issue":"Suppl.","key":"10.1016\/j.jns.2015.07.001_bb0130","first-page":"S4","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jns.2015.07.001_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1037\/h0044509","article-title":"The relation of the trail making test to organic brain damage","volume":"19","author":"Reitan","year":"1955","journal-title":"J. Consult. Psychol."},{"key":"10.1016\/j.jns.2015.07.001_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00005053-195909000-00006","article-title":"Differential effects of lateralized brain lesions on the trail making test","volume":"129","author":"Reitan","year":"1959","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jns.2015.07.001_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0304-3940(02)01481-7","article-title":"Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease","volume":"339","author":"Schonknecht","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2015.07.001_bb0150","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","article-title":"CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings","volume":"78","author":"Sepp\u00e4l\u00e4","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.07.001_bb0155","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2015.07.001_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF tau, A beta 1\u201340 and A beta 1\u201342(43) as a biochemical marker of Alzheimer's disease","volume":"158","author":"Shoji","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2015.07.001_bb0165","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","article-title":"Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis","volume":"2","author":"Silverberg","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2015.07.001_bb0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3171\/jns.2002.97.6.1271","article-title":"Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus","volume":"97","author":"Silverberg","year":"2002","journal-title":"J. Neurosurg."},{"issue":"1 Pt 2","key":"10.1016\/j.jns.2015.07.001_bb0175","first-page":"R195","article-title":"Strong conservation of the expression of cystatin C gene in choroid plexus","volume":"263","author":"Tu","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jns.2015.07.001_bb0180","doi-asserted-by":"crossref","first-page":"9070","DOI":"10.1073\/pnas.90.19.9070","article-title":"Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain","volume":"90","author":"Urade","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2015.07.001_bb0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15004220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15004220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:45:47Z","timestamp":1758383147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15004220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0022510X15004220"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.07.001","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}